FSD Pharma and Celly Nu Enter Into Arrangement Agreement
accesswire.com/790197/fsd-pha…
#Nasdaq #Markets #Business #Beverage #UNBUZZD #Drinks #Lifestyle
00:00
Quantum BioPharma
1,256 posts
Quantum BioPharma
@QuantumBP
Clinical-stage biotech targeting Multiple Sclerosis & Alcohol Health. Creators of unbuzzd™️ & Lucid-MS™️. Diversified Treasury. NASDAQ: $QNTM
- The myelin sheath is a critical component of nerve fibers, which are responsible for conducting electrical signals in the nervous system. It plays a crucial role in facilitating the rapid and efficient transmission of these signals. In individuals with Multiple Sclerosis, the
00:00 - FSD Pharma Files Management Information Circular for Proposed Arrangement with Celly Nu PR News Release -> accesswire.com/795456/fsd-pha… #Alcohol #Lifestyle #Beverage #Dietary #Drinks #Shareholders #Nasdaq #UNBUZZD
00:00 
00:00- Globally, there are 2.9 million individuals living with Multiple Sclerosis. FSD Pharma is developing "Lucid-MS" as an innovative remyelination therapy in preclinical models. Our oral candidate, Lucid-MS, designed for various forms of Multiple Sclerosis (MS), has demonstrated
- Millions of people worldwide are affected by #mentalhealth disorders & #MultipleSclerosis every day, & currently, there is no known cure. #FSDPharma is working tirelessly to develop & bring potential treatments to market and obtain #TotalBrainHealth: fal.cn/3k2mE $HUGE
- In @BioTuesdays, #FSDPharma Co-Founder and Interim CEO Anthony Durkacz discusses our goal of #TotalBrainHealth. Get the details on the potential our drug candidates have to treat neuropsychiatric disorders, neurodegeneration and inflammation: bit.ly/3CFrVMc $HUGE
- FSD Pharma Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302 (Lucid-MS) for Ethics Committee Review in Australia. accesswire.com/860171/fsd-pha… #Biotech #MS #Multiplesclerosis #MSawarenessmonth #MSawarenessday #Clinicaltrials #NonImmunomodulatory
- Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing globenewswire.com/news-release/2… #NASDAQ $QNTM
00:00 - Quantum Biopharma Announces Advocate Against Naked Short Selling and Stock Manipulation, Kevin Malone (@Malone_Wealth) Appointed as Board Advisor. globenewswire.com/news-release/2… #QNTM #News #Investors #Nasdaq #Biotech $QNTM
- Quantum BioPharma has submitted its patented MS drug candidate, Lucid-21-302 (Lucid-MS), to the UK’s Innovative Licensing and Access Pathway (ILAP) fast-track program. Lucid-MS is a first-in-class treatment targeting demyelination in Multiple Sclerosis. The ILAP submission
00:00 - Quantum BioPharma Announces First Person with Multiple Sclerosis (MS) Scanned in Joint Study with Massachusetts General Hospital Joint Clinical Study with Massachusetts General Hospital Could Pave the Way for Testing Efficacy of Quantum’s Investigational MS drug, Lucid-21-302
00:00 - .@proactive_NA recaps our recent appointment of Dr. Eleanor N. Fish to our Research and Clinical Advisory Board, noting how Dr. Fish’s research & expertise in the areas of immunology & inflammatory disorders will make her an asset to #FSDPharma: bit.ly/3wZVvdN $HUGE
- Stay up to date on #FSDPharma's latest happenings by heading to the #news and #media coverage section of our website: fal.cn/3k4jg $HUGE